There are several risks associated with the use of percutaneous AngioJet thrombectomy, none of which are common, but all of which require some knowledge of the issues to prevent complications.
Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...
Boston Scientific (NYSE: BSX) has received United States (U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJet™ ZelanteDVT™ thrombectomy catheter to treat deep vein ...
Boston Scientific Corporation BSX is in the process of conducting a Medical Device Correction of certain AngioJet Ultra Consoles, which were shipped to customers without the required operator’s manual ...
NEW YORK (CBS.MW) -- Shares of Possis Medical plummeted almost 40 percent Tuesday after the company disclosed disappointing results in a study of its AngioJet catheter, used for the removal of blood ...
Disappointing trial data regarding the AngioJet catheter takes a 38% bite out of Possis Medical's stock. Shares of device maker Possis Medical (NASDAQ:POSS) are down 38% to $19.20 after the company ...
Background A 43-year-old African-American female (gravida 5 para 0) with an 8-week intrauterine pregnancy presented to the emergency room with crampy abdominal pain, shortness of breath, and shoulder ...
RAWALPINDI: An angiojet machine worth Rs13.5 million has been installed at the Rawalpindi Institute of Cardiology (RIC). The latest technology is used to remove blood clots from the arteries in ...
Boston Scientific Corporation BSX is in the process of conducting a Medical Device Correction of certain AngioJet Ultra Consoles, which were shipped to customers without the required operator’s manual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results